Back
Compare AU
Compare AAA vs. CURE
Compare shares and ETFs on the ASX that you can trade on Pearler.
Overview
When it comes to investing in the Australian stock market, shares and ETFs are a popular choice. Two options in the ASX are AAA and CURE. In this comparison, we'll delve into these options across various dimensions to help you make an informed investment decision.
Community Stats
AAA | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 236 | 71 |
Median incremental investment | $4,300.00 | $684.93 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,206.60 | $2,419.52 |
Average age group | > 35 | > 35 |
Key Summary
AAA | CURE | |
|---|---|---|
Strategy | AAA.AX was created on 2012-03-06 by BetaShares. The fund's investment portfolio concentrates primarily on target outcome asset allocation. The Fund aims to provide exposure to Australian cash, with attractive and regular incomedistributions that exceed the 30 day Bank Bill Swap Rate (after fees and expenses). | CURE.AX was created on 2018-11-08 by Global X. The fund's investment portfolio concentrates primarily on health care equity. The Fund aims to provide investors with a return that (before fees and expenses) tracks the performance of the S&P Biotechnology Select Industry Index. |
Top 3 holdings | Betashares Australian High Interest Cash ETF (100 %) | Moderna Inc (1.55 %) Apogee Therapeutics Inc (1.45 %) Kymera Therapeutics Inc Ordinary Shares (1.37 %) |
Top 3 industries | Communication Services (100.00 %) | Health Care (100.00 %) Other (10.24 %) |
Top 3 countries | United States (96.62 %) United Kingdom of Great Britain and Northern Ireland (1.35 %) Switzerland (1.13 %) | |
Management fee | 0.18 % | 0.45 % |
Key Summary
AAA | CURE | |
|---|---|---|
Issuer | BetaShares | Global X |
Tracking index | S&P Biotechnology Select Industry | |
Asset class | ETF | ETF |
Management fee | 0.18 % | 0.45 % |
Price | $50.15 | $75.61 |
Size | $5.015 billion | $53.152 million |
10Y return | 0.02 % | N/A |
Annual dividend/ distribution yield (5Y) | 2.40 % | 0.03 % |
Market | ASX | ASX |
First listed date | 07/03/2012 | 12/11/2018 |
Purchase fee | $6.50 | $6.50 |
Community Stats
AAA | CURE | |
|---|---|---|
Popularity | Low | Low |
Pearlers invested | 236 | 71 |
Median incremental investment | $4,300.00 | $684.93 |
Median investment frequency | Monthly | Monthly |
Median total investment | $2,206.60 | $2,419.52 |
Average age group | > 35 | > 35 |
Pros and Cons
AAA | CURE | |
|---|---|---|
Pros |
|
|
Cons |
|
|
AAA | CURE |
|---|---|
Lower exposure to US market | Higher exposure to US market |
Lower management fee | Higher management fee |
Lower price growth | Higher price growth |
Higher distribution yield | Lower distribution yield |